Diagnosis of sarcopenic obesity in Japan: Consensus statement of the Japanese Working Group on Sarcopenic Obesity.
algorithm
definition
diagnostic criteria
sarcopenic obesity
Journal
Geriatrics & gerontology international
ISSN: 1447-0594
Titre abrégé: Geriatr Gerontol Int
Pays: Japan
ID NLM: 101135738
Informations de publication
Date de publication:
10 Sep 2024
10 Sep 2024
Historique:
revised:
11
08
2024
received:
27
06
2024
accepted:
21
08
2024
medline:
10
9
2024
pubmed:
10
9
2024
entrez:
10
9
2024
Statut:
aheadofprint
Résumé
Sarcopenic obesity is the co-existence of obesity and sarcopenia in individuals aged 40-75 years. The Japanese Working Group on Sarcopenic Obesity has developed diagnostic criteria tailored for the Japanese population, considering their unique characteristics compared with European populations. Our algorithm consists of two steps: screening and diagnosis. The screening of obesity mandates using waist circumference and/or body mass index (BMI) based on national standards, while screening for sarcopenia involves the "finger ring test" in addition to the Asian Working Group for Sarcopenia 2019 criteria. The final diagnosis of sarcopenia involves handgrip strength for low muscle strength, the five-times chair stand test for low physical function, and limb skeletal muscle mass (corrected for BMI) for low muscle mass. Obesity is assessed by visceral fat area or body fat percentage. Sarcopenic obesity is then categorized into Stage I, with muscle weakness/loss of function, loss of muscle mass, and obesity; or Stage II, which includes complications. Further clinical validation is needed to refine the consensus and age range. Geriatr Gerontol Int 2024; ••: ••-••.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Geriatrics & Gerontology International published by John Wiley & Sons Australia, Ltd on behalf of Japan Geriatrics Society.
Références
Donini LM, Busetto L, Bauer JM et al. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clin Nutr 2020; 39: 2368–2388.
Kawakami R, Murakami H, Sanada K et al. Calf circumference as a surrogate marker of muscle mass for diagnosing sarcopenia in Japanese men and women. Geriatr Gerontol Int 2015; 15: 969–976.
Donini LM, Busetto L, Bischoff SC et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin Nutr 2022; 41: 990–1000.
Ogawa W, Hirota Y, Miyazaki S et al. Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocr J 2024; 71: 223–231.
Caleyachetty R, Barber TM, Mohammed NI et al. Ethnicity‐specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population‐based cohort study. Lancet Diabetes Endocrinol 2021; 9: 419–426.
Ayabe M, Kumahara H, Yamaguchi‐Watanabe A et al. Appendicular muscle mass and exercise/sports participation history in young Japanese women. Ann Hum Biol 2019; 46: 335–339.
Tanaka T, Takahashi K, Akishita M, Tsuji T, Iijima K. "Yubi‐wakka" (finger‐ring) test: a practical self‐screening method for sarcopenia, and a predictor of disability and mortality among Japanese community‐dwelling older adults. Geriatr Gerontol Int 2018; 18: 224–232.
Chen LK, Woo J, Assantachai P et al. Asian working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 2020; 21: 300–307.e2.
Kinoshita K, Satake S, Matsui Y, Arai H. Association between sarcopenia and fall risk according to the muscle mass adjustment method in Japanese older outpatients. J Nutr Health Aging 2021; 25: 762–766.
Studenski SA, Peters KW, Alley DE et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 2014; 69: 547–558.
Japan Society for the Study of the Obesity. Manual of the Treatment of Obesity, 2nd edn. Tokyo: Ishiyaku Publishers INC, 2001; 5 (Article in Japanese).